Evaluating clinical effectiveness and safety of pneumococcal immunization of infants

According to WHO, pneumococcal infection (PI) is considered one of the most dangerous of all vaccine-preventable diseases and, before vaccination, led to the death of up to 1.6 million people per year, of which from 0.7 to 1 million were children. In the prevention of PI, specific prevention occupies a special place. For the first time in 2014, vaccination against PI with pneumococcal conjugate vaccine was included in the national calendar of preventive vaccinations. International practice of using pneumococcal vaccine has shown that timely vaccination can produce positive results in the fight against PI. Under observation were 55 children who were vaccinated against PI with the pneumococcal polysaccharide conjugate vaccine (adsorbed), 13 valent according to the national calendar of preventive vaccinations of the Russian Federation. It was revealed that post-vaccination complications after vaccination did not occur in any child. General post-vaccination reactions were observed in the form of a short-term increase in temperature, loss of appetite and sleep disturbances, as well as local reactions in the form of edema, hyperemia, and hardening at the site of vaccine administration. We studied the incidence of community-acquired pneumonia (CAP), acute otitis media and acute respiratory infections among 55 children of the first year of life vaccinated at 2 months and 4.5 months (main group) and 50 children for various reasons not vaccinated against PI (comparison group). A study of the long-term results of 2-fold vaccination in the first year of life and revaccination at 15 months against PV based on observation of children for two years showed that children of the main group, compared with the comparison group, were 3.3 times less likely to suffer from PV, 2.7 times acute otitis and 1.7 times acute respiratory infections, p < 0.05. The data obtained show the high efficiency and safety of vaccinating children against PI with the pneumococcal vaccine.

1. Baranov AA, Namazova-Baranova LS, Mayanskiy NA, Kulichenko TV, Polunina TA, Lazareva AV et al. Role of Streptococcus pneumoniae in the structure of bacterial infections in the children hospitalized to inpatient hospitals in Moscow in 2011–2012. Pediatric Pharmacology. 2013;10(5):6–12. (In Russ.) https://doi.org/10.15690/pf.v10i5.816.

2. Kozlov RS, Krechikova OI, Muravyev AA, Mironov KO, Platonov AE, Dunaeva EA et al. Incidence of Community-Acquired Pneumonia and Acute Otitis Media in Children 0–5 Years in Russia and Role of S. pneumonia or H. influenzae in the Etiology of the Diseases. Klinicheskaia Mikrobiologiia i Antimikrobnaia Khimioterapiia. 2013;15(4):246–260. (In Russ.) Available at: https://cmac-journal.ru/publication/2013/4/cmac2013-t15-n4-p246/cmac-2013-t15-n4-p246.pdf.

3. Геппе НА, Розинова НН, Волков ИК, Козлова ЛВ, Малахов АБ, Манеров ФК, Мизерницкий Ю.Л. Внебольничная пневмония у детей: клинические рекомендации. М.: Оригинал-макет; 2015. 64 с. Режим доступа: https://studfile.net/preview/7385680/.

4. Geppe NA, Malakhov AB, Dronov IA, Khabibullina EA. Community-Acquired Pneumonia in Children: Diagnosis, Treatment and Prevention Challenges. Doktor.Ru. 2015;(13):28–30. (In Russ.) Available at: https://journaldoctor.ru/catalog/pediatriya/vnebolnichnaya-pnevmoniya-u-detey-problemydiagnostiki-lecheniya-i-profilaktiki/.

5. Ginsburg AS, Lenahan JL, Izadnegahdar R, Ansermino JM. A Systematic Review of Tools to Measure Respiratory Rate in Order to Identify Childhood Pneumonia. Am J Respir Crit Care Med. 2018;197(9):1116–1127. https://doi.org/10.1164/rccm.201711-2233CI.

6. Ezhlova EB, Melnikova AA, Baranov AA, Namazova-Baranova LS, Tatochenko VK, Zverev VV et al. Vaccine epidemiology and infection caused by Streptococcus pneumoniae. Methodological recommendations. Vaccination. 2011;1(2):36–47. (In Russ.) Available at: http://vaccination.su/article.php?what=122.

7. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7(10):e1000348. https://doi.org/10.1371/journal.pmed.1000348.

8. Destefano F, Pfeifer D, Nohynek H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bull World Health Organ. 2008;86(5):373–380. https://doi.org/10.2471/blt.07.048025.

9. Thomas J, Pociute A, Kevalas R, Malinauskas M, Jankauskaite L. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020;46(1):4. https://doi.org/10.1186/s13052-020-0770-3.

10. Bhuiyan MU, Blyth CC, West R, Lang J, Rahman T, Granland C et al. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children. BMC Pulm Med. 2019;19(1):71. https://doi.org/10.1186/s12890-019-0835-5.

11. American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126(1):186–190. https://doi.org/10.1542/peds.2010-1280.

12. Sidorenko S, Lobzin Yu, Kharit S, Koroleva I, Tatochenko V. Pneumococcal infection and modern opportunities of its prophylaxis – epidemiological review of situation in the world and Russia. Current Pediatrics. 2010;9(1): 62–69. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/829.

13. Baranov AA, Namazova-Baranova LS, Briko NI, Lobzin YV, Tatochenko VK, Kharit SM et al. Vaccinal Prevention of Pneumococcal Infection in Children. Pediatric Pharmacology. 2015;12(5):550–558. https://doi.org/10.15690/pf.v12i5.1457.

14. Баранов АА, Козлов РС, Намазова-Баранова ЛС, Андреева ИВ, Бакрадзе МД, Вишнева ЕА и др. Пневмония (внебольничная): клинические рекомендации. 2022-2023-2024. (18.01.2022). Режим доступа: https://gbpokachi.ru/upload/medialibrary/bfd/jnypib44ohjx7da51ymksgbqqaq6odw9.pdf